ENKAM PHARMACEUTICALS ApS: Financial statements 2017
CVR: 25812921
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
ENKAM PHARMACEUTICALS ApS (CVR 25812921) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -239,433 and a net result of DKK -277,379 compared with DKK -345,030 the year before. Equity in the 2017 report amounted to DKK -885,809.
- Gross Profit
- DKK -239,433
- Profit/Loss
- DKK -277,379
- Equity
- DKK -885,809
- Total Assets
- DKK 20,914
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -239 t. | -277 t. | -886 t. | 0 |
| 2016 | - | -272 t. | -345 t. | -608 t. | 0 |
| 2015 | - | -426 t. | -488 t. | -263 t. | - |
| 2014 | - | 4.7 mio. | 2.8 mio. | -1.9 mio. | - |
| 2013 | - | -2.6 mio. | -3.7 mio. | -4.7 mio. | - |
Official annual report
Keep an eye on ENKAM PHARMACEUTICALS ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
ENKAM PHARMACEUTICALS ApS has published its annual report for 2016. Gross profit came to DKK -271,767, and the net result was DKK -345,030.
As of May 24, 2017, Jan Evert Lilja has left the board of directors of ENKAM PHARMACEUTICALS ApS.
About ENKAM PHARMACEUTICALS ApS
ENKAM PHARMACEUTICALS ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2000. The company has been dissolved on 15 July 2021. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named ENKAM PHARMACEUTICALS A/S. The company has 1 employee (2019). In 2018, the company reported a gross profit of DKK -275,740 and a net result of DKK -293,665 compared with DKK -277,379 the year before. Equity in the 2018 report amounted to DKK -1,179,474.